- Home
- INBS vs PHIO Comparison
INBS vs PHIO Comparison
Compare INBS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- PHIO
- Stock Information
- Founded
- INBS 2016
- PHIO 2011
- Country
- INBS United States
- PHIO United States
- Employees
- INBS N/A
- PHIO N/A
- Industry
- INBS Medical Specialities
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- PHIO Health Care
- Exchange
- INBS Nasdaq
- PHIO Nasdaq
- Market Cap
- INBS 8.7M
- PHIO 8.6M
- IPO Year
- INBS N/A
- PHIO N/A
- Fundamental
- Price
- INBS $1.53
- PHIO $2.16
- Analyst Decision
- INBS
- PHIO Strong Buy
- Analyst Count
- INBS 0
- PHIO 2
- Target Price
- INBS N/A
- PHIO $9.00
- AVG Volume (30 Days)
- INBS 152.0K
- PHIO 703.0K
- Earning Date
- INBS 05-13-2025
- PHIO 08-13-2025
- Dividend Yield
- INBS N/A
- PHIO N/A
- EPS Growth
- INBS N/A
- PHIO N/A
- EPS
- INBS N/A
- PHIO N/A
- Revenue
- INBS $2,936,472.00
- PHIO N/A
- Revenue This Year
- INBS $280.88
- PHIO N/A
- Revenue Next Year
- INBS $126.26
- PHIO N/A
- P/E Ratio
- INBS N/A
- PHIO N/A
- Revenue Growth
- INBS 3.87
- PHIO N/A
- 52 Week Low
- INBS $1.00
- PHIO $0.97
- 52 Week High
- INBS $3.00
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- INBS 42.41
- PHIO 50.19
- Support Level
- INBS $1.72
- PHIO $2.11
- Resistance Level
- INBS $1.86
- PHIO $2.30
- Average True Range (ATR)
- INBS 0.15
- PHIO 0.21
- MACD
- INBS -0.04
- PHIO -0.04
- Stochastic Oscillator
- INBS 1.61
- PHIO 9.65
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.